N-(1-Benzylpiperidin-4-yl)-4-iodobenzamide

Catalog No. :
ACUKOM931
CAS No. :
155798-08-6
Molecular Formula :
C19H21IN2O
Molecular Weight :
420.29

IUPAC Name:N-(1-benzylpiperidin-4-yl)-4-iodobenzamide

N-(1-Benzylpiperidin-4-yl)-4-iodobenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$76.00Login to see priceIn stockInquiry
250mg98%$130.00Login to see priceIn stockInquiry
1g98%$349.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(1-Benzylpiperidin-4-yl)-4-iodobenzamide
IUPAC NameN-(1-benzylpiperidin-4-yl)-4-iodobenzamide
Molecular FormulaC19H21IN2O
Molecular Weight420.29
SMILESO=C(NC1CCN(CC2=CC=CC=C2)CC1)C3=CC=C(I)C=C3
InChI KeyHELCSESNNDZLFM-UHFFFAOYSA-N
Synonym4-IBP;N-(N-BENZYLPIPERIDIN-4-YL)-4-IODOBENZAMIDE;4 IBP;4IBP;Benzamide, 4-iodo-N-[1-(phenylmethyl)-4-piperidinyl]-;N-(1-benzyl-4-piperidinyl)-4-iodobenzamide;4IBP,Inhibitor,Sigma Receptor,inhibit,4 IBP,4-IBP;4-IBP, 10 mM in DMSO
CAS No.155798-08-6
PubChem CID132995

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACUKOM931 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACISVW287 route compound structure diagram
    ACISVW28750541-93-0 In Stock
  2. Plus
  3. ACBLYH147 route compound structure diagram
    ACBLYH147619-58-9 In Stock
  4. Then
  5. ACUKOM931 route product structure diagram
    ACUKOM931155798-08-6 In Stock
Inquiry

2. ACUKOM931 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACISVW287 route compound structure diagram
    ACISVW28750541-93-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUKOM931 route product structure diagram
    ACUKOM931155798-08-6 In Stock
Inquiry

Comments (0)